Project Summary With the discovery of the CRISPR/Cas system, human genome engineering has been revolutionized, enabling a large number of genome editing operations. Our ability to control human genome editing events therefore directly affects downstream biomedical research. However, while the generation of biallelic knockouts has become a highly efficient process, our ability to efficiently generate biallelic knock-ins is still severely limited. Key reasons for this are that in addition to a Cas-mediated endonucleolytic cleavage event the following hurdles need to be overcome: First, homologous recombination needs to occur on both alleles. Second with a single DNA repair template it is difficult to reliably distinguish monoallelic from biallelic editing at a single cell level. Third, in cases where two DNA repair templates are used, biallelically edited cells can be selected but the overall efficiency is further reduced. There is hence an urgent need for new technologies that enable efficient biallelic editing together with powerful selection strategies. We hypothesize that this critical need can be addressed by synergistically employing a Cas enzyme in conjunction with DNA recombination and BOOLEAN logic AND gates. Based on these ideas we propose to develop a new genome editing platform, focusing on two specific aims: (1) To facilitate biallelic genome editing with a single DNA repair template and DNA recombination and (2) To develop a split reporter system that constitutes a BOOLEAN logic AND gate so that biallelically edited clones can be selected with high efficiency. These new approaches will significantly increase our ability to perform efficient biallelic human genome editing and integrate biologic gates into this process, thus having widespread and immediate impact across biomedical sciences.